The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for LI-COR sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights LI-COR Inc, United States Revenue

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

LCB, doing business as LI-COR Biosciences, is a medical device company that offers environmental and biotechnology products. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnology, plant biology, drug discovery and environmental research. LCB’s products portfolio include genomics reagents, western blot reagents, protease assay reagents, other optical imaging reagents, pearl cam software and protein gel combs. The company’s products are used in gas analysis, eddy covariance, photosynthesis, soil gas flux, light measurement, and other applications. It markets its products through a network of distributors in Africa, Asia, Europe, and North and Central America. LCB is headquartered in Lincoln, Nebraska, the US. Key subsidiaries of LI-COR include Anemoment, LI COR, LI-COR Biosciences and LI-COR Biosciences.

The key metrics of LI-COR related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As LI-COR is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as LI-COR.

For a detailed understanding of the performance of LI-COR, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.